This is a Validated Antibody Database (VAD) review about human interleukin 2, based on 94 published articles (read how Labome selects the articles), using interleukin 2 antibody in all methods. It is aimed to help Labome visitors find the most suited interleukin 2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
interleukin 2 synonym: IL-2; TCGF; lymphokine

others
  • flow cytometry; human; loading ...; fig 6d
 interleukin 2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 6d). Nature (2019) ncbi
 interleukin 2 antibody (BioLegend, MQ1-17H12) was used . J Immunol (2019) ncbi
 interleukin 2 antibody (BioLegend, MQ1-17H12) was used . Sci Rep (2018) ncbi
BioLegend
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; 1:100; fig 4i
BioLegend interleukin 2 antibody (Biolegend, 500326) was used in flow cytometry on human samples at 1:100 (fig 4i). Nat Med (2021) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; fig 1c
BioLegend interleukin 2 antibody (Biolegend, 500310) was used in flow cytometry on human samples (fig 1c). Cell Host Microbe (2021) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig s5c
BioLegend interleukin 2 antibody (Biolegend, 500326) was used in flow cytometry on human samples (fig s5c). Science (2021) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 2d
BioLegend interleukin 2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples (fig 2d). Acta Neuropathol (2021) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 7e
BioLegend interleukin 2 antibody (Biolegend, 500337) was used in flow cytometry on human samples (fig 7e). Am J Respir Crit Care Med (2021) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 3g
BioLegend interleukin 2 antibody (Biolegend, 500320) was used in flow cytometry on human samples (fig 3g). Cell (2021) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; 1:200; loading ...; fig s5
BioLegend interleukin 2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples at 1:200 (fig s5). J Clin Invest (2020) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
BioLegend interleukin 2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples . J Immunother Cancer (2020) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 6d
BioLegend interleukin 2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 6d). Nature (2019) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 1b
BioLegend interleukin 2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 1b). J Immunol (2019) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 3e
BioLegend interleukin 2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 3e). J Exp Med (2019) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 1b
BioLegend interleukin 2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 1b). J Virol (2019) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; 1:100; loading ...; fig 2e
BioLegend interleukin 2 antibody (Biolegend, 500328) was used in flow cytometry on human samples at 1:100 (fig 2e). Nat Med (2019) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 4c
BioLegend interleukin 2 antibody (BioLegend, 500310) was used in flow cytometry on human samples (fig 4c). J Clin Invest (2018) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 6b
BioLegend interleukin 2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 6b). Sci Rep (2018) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig s2b
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, BioLegend interleukin 2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples (fig s2b). Nature (2017) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend interleukin 2 antibody (BioLegend, 500331) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; rhesus macaque; loading ...; fig 3a
In order to study CXCR5+ CD8 T cells in SIV-infected animals, BioLegend interleukin 2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on rhesus macaque samples (fig 3a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (MQ1-17H12)
  • ELISA; human; loading ...; fig 4e
  • ELISA; mouse; loading ...; fig 5a
In order to identify protein arginine methyltransferase 5 as an important modulator of CD4(+) T cell expansion, BioLegend interleukin 2 antibody (BioLegend, 500302) was used in ELISA on human samples (fig 4e) and in ELISA on mouse samples (fig 5a). J Immunol (2017) ncbi
domestic goat polyclonal (Poly5176)
  • ELISA; mouse; loading ...; fig 5a
  • ELISA; human; loading ...; fig 4e
In order to identify protein arginine methyltransferase 5 as an important modulator of CD4(+) T cell expansion, BioLegend interleukin 2 antibody (BioLegend, 517605) was used in ELISA on mouse samples (fig 5a) and in ELISA on human samples (fig 4e). J Immunol (2017) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; rhesus macaque; loading ...; tbl 1
In order to establish the ability of the herpes simplex virus-1 VC2 vaccine to elicit immune responses in rhesus macaques, BioLegend interleukin 2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on rhesus macaque samples (tbl 1). Vaccine (2017) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, BioLegend interleukin 2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples . Clin Immunol (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 5a
BioLegend interleukin 2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples (fig 5a). Cytokine (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend interleukin 2 antibody (BioLegend, 500331) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 3a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend interleukin 2 antibody (biolegend, MQ1-17H12) was used in flow cytometry on human samples (fig 3a). J Immunol (2016) ncbi
rat monoclonal (MQ1-17H12)
  • immunocytochemistry; human; fig 6
BioLegend interleukin 2 antibody (BioLegend, MQ1-17H12) was used in immunocytochemistry on human samples (fig 6). J Hematol Oncol (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, BioLegend interleukin 2 antibody (Biolegend, clone MQ1-17H12) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; 2 ul/test
In order to analyze mucosal pinch biopsies collected predominantly during colonoscopies, BioLegend interleukin 2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples at 2 ul/test. J Immunol Methods (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
BioLegend interleukin 2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
BioLegend interleukin 2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples . Med Microbiol Immunol (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
BioLegend interleukin 2 antibody (Biolegend, MQ1-17H12) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 4
BioLegend interleukin 2 antibody (BioLegend, MQ1-17H12) was used in flow cytometry on human samples (fig 4). J Immunol (2014) ncbi
Invitrogen
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig s1g
Invitrogen interleukin 2 antibody (eBioscience, MQ1-17H12) was used in flow cytometry on human samples (fig s1g). J Immunol (2018) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; rhesus macaque; loading ...; fig s9
Invitrogen interleukin 2 antibody (eBiosciences, MQ1-17H21) was used in flow cytometry on rhesus macaque samples (fig s9). PLoS Pathog (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, Invitrogen interleukin 2 antibody (eBioscience, MQ1-17H12) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (AB12-3G4)
  • flow cytometry; human; loading ...; fig 1a
In order to examine the expression of CD300 molecules on natural killer cells, Invitrogen interleukin 2 antibody (eBiosciences, AB12-3G4) was used in flow cytometry on human samples (fig 1a). Sci Rep (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; fig s2
In order to determine the composition of Orai1 channels found at the endoplasmic reticulum-plasma membrane junction, Invitrogen interleukin 2 antibody (eBioscience, MQ1-17H12) was used in flow cytometry on human samples (fig s2). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; fig 2
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen interleukin 2 antibody (eBioscience, MQ1-17H12) was used in flow cytometry on human samples (fig 2). Cancer Immunol Res (2015) ncbi
mouse monoclonal (419A7A3)
  • immunocytochemistry; human
  • ELISA; human
In order to study IgG monolayers using atomic force microscopy analyses, Invitrogen interleukin 2 antibody (Life Technologies/Invitrogen Corporation, AHC0422) was used in immunocytochemistry on human samples and in ELISA on human samples . Biochim Biophys Acta (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
Invitrogen interleukin 2 antibody (eBioscience, MQ1-17H12) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, Invitrogen interleukin 2 antibody (eBioscience, MQ1-17H12) was used in flow cytometry on human samples . Chest (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
Invitrogen interleukin 2 antibody (eBioscience, MQ1-17H12) was used in flow cytometry on human samples . J Virol (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
Invitrogen interleukin 2 antibody (eBioscience, MQ1-17H12) was used in flow cytometry on human samples . J Immunol (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; fig 1
In order to investigate the impact of CCR6(+)CXCR3(+)CCR4(-) cells in latent tuberculosis infection, Invitrogen interleukin 2 antibody (eBioscience, MQ1-17H12) was used in flow cytometry on human samples (fig 1). J Immunol (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, Invitrogen interleukin 2 antibody (eBioscience, MQ1-17h12) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; fig s1
Invitrogen interleukin 2 antibody (eBioscience, MQ1-17H12) was used in flow cytometry on human samples (fig s1). PLoS Pathog (2011) ncbi
mouse monoclonal (297C16F11)
  • other; human; fig 4
In order to optimize surface plasmon resonance imaging technology, Invitrogen interleukin 2 antibody (Biosource, Invitrogen, AHC0722) was used in other on human samples (fig 4). Anal Biochem (2008) ncbi
mouse monoclonal (419A7A3)
  • ELISA; human; 1 ug/ml; tbl 1
In order to explore the immunomodulatory effects of insulin-like growth factor through regulation of cytokine production, Invitrogen interleukin 2 antibody (Biosource, 419A7A3) was used in ELISA on human samples at 1 ug/ml (tbl 1). J Leukoc Biol (2004) ncbi
mouse monoclonal (297C16G2)
  • ELISA; human; 0.5 ug/ml; tbl 1
In order to explore the immunomodulatory effects of insulin-like growth factor through regulation of cytokine production, Invitrogen interleukin 2 antibody (Biosource, 297C1662) was used in ELISA on human samples at 0.5 ug/ml (tbl 1). J Leukoc Biol (2004) ncbi
Abcam
domestic rabbit monoclonal (EPR2780)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 5c
Abcam interleukin 2 antibody (Abcam, ab92381) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 5c). J Immunol Res (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (LNKB-2)
  • other; human
Santa Cruz Biotechnology interleukin 2 antibody (Santa Cruz, sc-52017) was used in other on human samples . PLoS ONE (2015) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig s2c
Cell Signaling Technology interleukin 2 antibody (CST, 12239) was used in western blot on human samples (fig s2c). Mol Oncol (2021) ncbi
BD Biosciences
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...
BD Biosciences interleukin 2 antibody (BD Biosciences, 554567) was used in flow cytometry on human samples . Oncogene (2021) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; 1:400; loading ...; fig s6
BD Biosciences interleukin 2 antibody (BD Biosciences, 554567) was used in flow cytometry on human samples at 1:400 (fig s6). Science (2019) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; human; loading ...; fig s6b
BD Biosciences interleukin 2 antibody (BD, 563946) was used in flow cytometry on human samples (fig s6b). Cell (2019) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences interleukin 2 antibody (BD Biosciences, 560708) was used in flow cytometry on human samples (fig 2d). Cell Rep (2018) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences interleukin 2 antibody (BD, MQ1-17H12) was used in flow cytometry on human samples (fig 2a). J Immunol (2018) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; fig 5d
In order to generate T cells from cord blood hematopoietic progenitor cells transduced to express an antigen receptor as assess their ability to limit malignant cells and graft versus host disease, BD Biosciences interleukin 2 antibody (BD Biosciences, 554567) was used in flow cytometry on human samples (fig 5d). Oncoimmunology (2017) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; African green monkey; fig s4b
In order to optimize the dosing regimen of neutralizing anti-HIV-1 antibodies, BD Biosciences interleukin 2 antibody (BD, MQ1-17H12) was used in flow cytometry on African green monkey samples (fig s4b). Nature (2017) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; human; fig 5
In order to elucidate the effects of pathogen recognition receptors on dendritic cell maturation, HIV infection, and on the quality of HIV-specific cytotoxic T-cell activation, BD Biosciences interleukin 2 antibody (BD, 341116) was used in flow cytometry on human samples (fig 5). Eur J Immunol (2017) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; mouse; loading ...; fig s6d
In order to assess the effects of targeting the chimeric antigen receptors to the TRAC locus, BD Biosciences interleukin 2 antibody (BD Horizon, 5344.111) was used in flow cytometry on mouse samples (fig s6d). Nature (2017) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; human; loading ...; fig 6c
In order to use CD49a expression to define subsets of tissue-resident memory T cells in the skin, BD Biosciences interleukin 2 antibody (BD Bioscience, 5344.111) was used in flow cytometry on human samples (fig 6c). Immunity (2017) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences interleukin 2 antibody (BD Biosciences, 340450) was used in flow cytometry on human samples (fig 5a). Oncoimmunology (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; rhesus macaque; loading ...; fig 8a
BD Biosciences interleukin 2 antibody (BD, 559334) was used in flow cytometry on rhesus macaque samples (fig 8a). Sci Rep (2016) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; human; loading ...; fig s2c
BD Biosciences interleukin 2 antibody (BD Biosciences, 340448) was used in flow cytometry on human samples (fig s2c). Cell (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 2e
In order to report the O-linked N-acetylglucosamine glycoproteome observed in human T cells, BD Biosciences interleukin 2 antibody (BD Biosciences, 559334) was used in flow cytometry on human samples (fig 2e). J Immunol (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; fig 5
BD Biosciences interleukin 2 antibody (BD PharMingen, 560902) was used in flow cytometry on human samples (fig 5). Stem Cell Reports (2016) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; human; loading ...; fig 1c
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, BD Biosciences interleukin 2 antibody (BD, 5344.111) was used in flow cytometry on human samples (fig 1c). Clin Immunol (2016) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; human; loading ...; fig 2e
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, BD Biosciences interleukin 2 antibody (BD Biosciences, 5344.111) was used in flow cytometry on human samples (fig 2e). J Clin Invest (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; fig 2
BD Biosciences interleukin 2 antibody (BD Bioscience, 554567) was used in flow cytometry on human samples (fig 2). Oncoimmunology (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...
In order to report that IgA-producing plasma cells are a major source of inducible NO synthase in Helicobacter pylori-infected patients, BD Biosciences interleukin 2 antibody (BD, MQ1-17H12) was used in flow cytometry on human samples . J Immunol (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences interleukin 2 antibody (BD, MQ1-17H2) was used in flow cytometry on human samples (fig s1b). J Immunol (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences interleukin 2 antibody (BD Pharmingen, MQ1-17H12) was used in flow cytometry on human samples (fig s1). J Immunol (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; rhesus macaque; loading ...; fig st5
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BD Biosciences interleukin 2 antibody (Beckman Coulter, 554566) was used in flow cytometry on rhesus macaque samples (fig st5). Nat Med (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences interleukin 2 antibody (BD Biosciences, MQ1-17H12) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; tbl 2
In order to characterize the immune responses of children immunized with Plasmodium falciparum apical membrane antigen 1, BD Biosciences interleukin 2 antibody (BD Biosciences, MQ1-17H12) was used in flow cytometry on human samples (tbl 2). Vaccine (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; rhesus macaque; loading ...
BD Biosciences interleukin 2 antibody (BD Biosciences, MQ1-17H12) was used in flow cytometry on rhesus macaque samples . PLoS ONE (2016) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; rhesus macaque; fig 3d
BD Biosciences interleukin 2 antibody (BD Biosciences, 5344.111) was used in flow cytometry on rhesus macaque samples (fig 3d). J Immunol (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; fig s1
In order to develop an HLA-A2-specific chimeric antigen receptor and use it to generate alloantigen-specific human T regulatory cells, BD Biosciences interleukin 2 antibody (BD Biosciences, 559334) was used in flow cytometry on human samples (fig s1). J Clin Invest (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; African green monkey; loading ...; fig 5a
In order to report that B cells modulate the local granulomatous response in Mycobacterium tuberculosis-infected macaques during acute infection, BD Biosciences interleukin 2 antibody (BD Biosciences, MQ1-17H12) was used in flow cytometry on African green monkey samples (fig 5a). Infect Immun (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; loading ...; fig 3b
BD Biosciences interleukin 2 antibody (BD Pharmingen, MQ1-17H12) was used in flow cytometry on human samples (fig 3b). PLoS ONE (2016) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; fig s2
In order to analyze HIV progression traits of a selective loss of early differentiated and highly functional PD1high CD4 T cells, BD Biosciences interleukin 2 antibody (BD Biosciences, MQ1-17H12) was used in flow cytometry on human samples (fig s2). PLoS ONE (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; rhesus macaque; fig 3
In order to assess the ability of HIV-1 envelope glycoprotein-specific broadly neutralizing monoclonal antibodies to suppress acute simian-human immunodeficiency virus replication in rhesus macaques, BD Biosciences interleukin 2 antibody (BD Biosciences, MQ1-17H12) was used in flow cytometry on rhesus macaque samples (fig 3). J Virol (2016) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; human; fig 2
  • flow cytometry; dogs; fig 2
BD Biosciences interleukin 2 antibody (BD, 340450) was used in flow cytometry on human samples (fig 2) and in flow cytometry on dogs samples (fig 2). Acta Vet Scand (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
In order to study the dynamics of Ag-specific CD4(+) T cells during antiretroviral therapy, BD Biosciences interleukin 2 antibody (BD Biosciences, MQ1-17H12) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; human; 1:40; fig 1
In order to study the immune responses of HIV-infected volunteers vaccinated against tuberculosis, BD Biosciences interleukin 2 antibody (BD, 340448) was used in flow cytometry on human samples at 1:40 (fig 1). Clin Vaccine Immunol (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human; 4:100; fig 3b
In order to show that hepatitis B virus exposure in utero enhances immunity to bacterial infections, BD Biosciences interleukin 2 antibody (Becton Dickinson, MQ1-17H12) was used in flow cytometry on human samples at 4:100 (fig 3b). Nat Commun (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
In order to measure the memory CD4(+) T-cell responses to each varicella zoster virus protein at baseline and after zoster vaccination, BD Biosciences interleukin 2 antibody (BD, MQ1-17H12) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; human
In order to assess the effects of long-term cryopreservation of fixed cells on the measurement of mycobacteria induced CD4 T cell immunity, BD Biosciences interleukin 2 antibody (BD Biosciences, 5344.111) was used in flow cytometry on human samples . J Immunol Methods (2015) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; human
BD Biosciences interleukin 2 antibody (BD Bioscience, 5344.11) was used in flow cytometry on human samples . Immun Inflamm Dis (2014) ncbi
mouse monoclonal (B33-2)
  • ELISA; human
BD Biosciences interleukin 2 antibody (BD Pharmingen, B33-2) was used in ELISA on human samples . J Autoimmun (2015) ncbi
mouse monoclonal (5344.111)
  • ELISA; human
BD Biosciences interleukin 2 antibody (BD Pharmingen, 5344.111) was used in ELISA on human samples . J Autoimmun (2015) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BD Biosciences interleukin 2 antibody (BD Pharmingen, 5344.111) was used in flow cytometry on human samples . Chest (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
BD Biosciences interleukin 2 antibody (BD, MQ1-17H12) was used in flow cytometry on human samples . J Immunol (2015) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
BD Biosciences interleukin 2 antibody (BD Biosciences, MQ1-17H12) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; rhesus macaque
BD Biosciences interleukin 2 antibody (BD Biosciences, MQ1-17H12) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
BD Biosciences interleukin 2 antibody (BD, MQ1-17H12) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (5344.111)
  • flow cytometry; human
In order to test the safety and immunogenicity of an adenovirus 35-vectored tuberculosis vaccine candidate AERAS-402 in infants, BD Biosciences interleukin 2 antibody (BD Biosciences, 5344.111) was used in flow cytometry on human samples . Vaccine (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
In order to test the safety and immunogenicity of an adenovirus 35-vectored tuberculosis vaccine candidate AERAS-402 in infants, BD Biosciences interleukin 2 antibody (BD Biosciences, Clone MQ1-17H12) was used in flow cytometry on human samples . Vaccine (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
BD Biosciences interleukin 2 antibody (BD Pharmingen, MQ1-17H12) was used in flow cytometry on human samples . J Virol (2014) ncbi
rat monoclonal (MQ1-17H12)
  • flow cytometry; human
BD Biosciences interleukin 2 antibody (BD Biosciences, MQ1-17H12) was used in flow cytometry on human samples . J Immunol (2014) ncbi
Articles Reviewed
  1. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed publisher
  2. Motozono C, Toyoda M, Zahradník J, Saito A, Nasser H, Tan T, et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe. 2021;29:1124-1136.e11 pubmed publisher
  3. Weber E, Parker K, Sotillo E, Lynn R, Anbunathan H, Lattin J, et al. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science. 2021;372: pubmed publisher
  4. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  5. Parveen S, Siddharth S, Cheung L, Kumar A, Shen J, Murphy J, et al. Therapeutic targeting with DABIL-4 depletes myeloid suppressor cells in 4T1 triple-negative breast cancer model. Mol Oncol. 2021;15:1330-1344 pubmed publisher
  6. Liu Y, Li X, Zhang H, Zhang M, Wei Y. HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer. Oncogene. 2021;40:2230-2242 pubmed publisher
  7. Snyder M, Sembrat J, Noda K, MYERBURG M, Craig A, Mitash N, et al. Human Lung-Resident Macrophages Colocalize with and Provide Costimulation to PD1hi Tissue-Resident Memory T Cells. Am J Respir Crit Care Med. 2021;203:1230-1244 pubmed publisher
  8. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher
  9. Cao W, Fang F, Gould T, Li X, Kim C, Gustafson C, et al. Ecto-NTPDase CD39 is a negative checkpoint that inhibits follicular helper cell generation. J Clin Invest. 2020;130:3422-3436 pubmed publisher
  10. Marotte L, Simon S, Vignard V, Dupré E, Gantier M, Cruard J, et al. Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. J Immunother Cancer. 2020;8: pubmed publisher
  11. Lynn R, Weber E, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293-300 pubmed publisher
  12. Crank M, Ruckwardt T, Chen M, Morabito K, Phung E, Costner P, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science. 2019;365:505-509 pubmed publisher
  13. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed publisher
  14. Canete P, Sweet R, Gonzalez Figueroa P, Papa I, Ohkura N, Bolton H, et al. Regulatory roles of IL-10-producing human follicular T cells. J Exp Med. 2019;: pubmed publisher
  15. Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango M, Kaufmann S, et al. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. Cell. 2019;: pubmed publisher
  16. Amelio P, Portevin D, Hella J, Reither K, Kamwela L, Lweno O, et al. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses. J Virol. 2019;93: pubmed publisher
  17. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed publisher
  18. Wagner D, Amini L, Wendering D, Burkhardt L, Akyüz L, Reinke P, et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat Med. 2019;25:242-248 pubmed publisher
  19. Kuranda K, Jean Alphonse P, Leborgne C, Hardet R, Collaud F, Marmier S, et al. Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. J Clin Invest. 2018;128:5267-5279 pubmed publisher
  20. Yang T, St John L, Garber H, Kerros C, Ruisaard K, Clise Dwyer K, et al. Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation. J Immunol. 2018;201:1389-1399 pubmed publisher
  21. Zhang C, Peng Y, Hublitz P, Zhang H, Dong T. Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy. Sci Rep. 2018;8:5549 pubmed publisher
  22. Wang C, Edilova M, Wagar L, Mujib S, Singer M, Bernard N, et al. Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy. J Immunol. 2018;200:558-564 pubmed publisher
  23. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher
  24. Van Caeneghem Y, De Munter S, Tieppo P, Goetgeluk G, Weening K, Verstichel G, et al. Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology. 2017;6:e1283460 pubmed publisher
  25. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed publisher
  26. Cardinaud S, Urrutia A, Rouers A, Coulon P, Kervevan J, Richetta C, et al. Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells. Eur J Immunol. 2017;47:818-829 pubmed publisher
  27. Eyquem J, Mansilla Soto J, Giavridis T, van der Stegen S, Hamieh M, Cunanan K, et al. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature. 2017;543:113-117 pubmed publisher
  28. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed publisher
  29. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  30. Mylvaganam G, Rios D, Abdelaal H, Iyer S, Tharp G, Mavigner M, et al. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection. Proc Natl Acad Sci U S A. 2017;114:1976-1981 pubmed publisher
  31. Parrot T, Oger R, Benlalam H, Raingeard de la Blétière D, Jouand N, Coutolleau A, et al. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells. Oncoimmunology. 2016;5:e1250991 pubmed publisher
  32. Webb L, Amici S, Jablonski K, Savardekar H, Panfil A, Li L, et al. PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis. J Immunol. 2017;198:1439-1451 pubmed publisher
  33. Stanfield B, Pahar B, Chouljenko V, Veazey R, Kousoulas K. Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies. Vaccine. 2017;35:536-543 pubmed publisher
  34. Berry N, Manoussaka M, Ham C, Ferguson D, Tudor H, Mattiuzzo G, et al. Role of Occult and Post-acute Phase Replication in Protective Immunity Induced with a Novel Live Attenuated SIV Vaccine. PLoS Pathog. 2016;12:e1006083 pubmed publisher
  35. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  36. Kaewkangsadan V, Verma C, Eremin J, Cowley G, Ilyas M, Eremin O. Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer. J Immunol Res. 2016;2016:4757405 pubmed
  37. Swaminathan G, Thoryk E, Cox K, Smith J, Wolf J, Gindy M, et al. A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates. Sci Rep. 2016;6:34215 pubmed publisher
  38. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed publisher
  39. Lund P, Elias J, Davis M. Global Analysis of O-GlcNAc Glycoproteins in Activated Human T Cells. J Immunol. 2016;197:3086-3098 pubmed
  40. Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016;7:619-634 pubmed publisher
  41. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed publisher
  42. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed publisher
  43. Peper J, Bösmüller H, Schuster H, Gückel B, Hörzer H, Roehle K, et al. HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy. Oncoimmunology. 2016;5:e1065369 pubmed publisher
  44. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed publisher
  45. Suliman S, Geldenhuys H, Johnson J, Hughes J, Smit E, Murphy M, et al. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. J Immunol. 2016;197:1100-1110 pubmed publisher
  46. Xie L, Zhou F, Liu X, Fang Y, Yu Z, Song N, et al. Serum microRNA181a: Correlates with the intracellular cytokine levels and a potential biomarker for acute graft-versus-host disease. Cytokine. 2016;85:37-44 pubmed publisher
  47. Coulon P, Richetta C, Rouers A, Blanchet F, Urrutia A, Guerbois M, et al. HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells. J Immunol. 2016;197:517-32 pubmed publisher
  48. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  49. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed publisher
  50. Graves S, Kouriba B, Diarra I, Daou M, Niangaly A, Coulibaly D, et al. Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate. Vaccine. 2016;34:2546-55 pubmed publisher
  51. Zurawski G, Zurawski S, Flamar A, Richert L, Wagner R, Tomaras G, et al. Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques. PLoS ONE. 2016;11:e0153484 pubmed publisher
  52. Dimitrova M, Zenarruzabeitia O, Borrego F, Simhadri V. CD300c is uniquely expressed on CD56 bright Natural Killer Cells and differs from CD300a upon ligand recognition. Sci Rep. 2016;6:23942 pubmed publisher
  53. Rueda C, Presicce P, Jackson C, Miller L, Kallapur S, Jobe A, et al. Lipopolysaccharide-Induced Chorioamnionitis Promotes IL-1-Dependent Inflammatory FOXP3+ CD4+ T Cells in the Fetal Rhesus Macaque. J Immunol. 2016;196:3706-15 pubmed publisher
  54. Macdonald K, Hoeppli R, Huang Q, Gillies J, Luciani D, Orban P, et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J Clin Invest. 2016;126:1413-24 pubmed publisher
  55. Woo J, Srikanth S, Nishi M, Ping P, Takeshima H, Gwack Y. Junctophilin-4, a component of the endoplasmic reticulum-plasma membrane junctions, regulates Ca2+ dynamics in T cells. Proc Natl Acad Sci U S A. 2016;113:2762-7 pubmed publisher
  56. Phuah J, Wong E, Gideon H, Maiello P, Coleman M, Hendricks M, et al. Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun. 2016;84:1301-1311 pubmed publisher
  57. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  58. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed publisher
  59. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed publisher
  60. Burbelo P, Klimavicz J, Deeks S, Kovacs J, Ragheb J. Lack of Evidence for Molecular Mimicry in HIV-Infected Subjects. PLoS ONE. 2015;10:e0127662 pubmed publisher
  61. Bolton D, Pegu A, Wang K, McGinnis K, Nason M, Foulds K, et al. Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs. J Virol. 2016;90:1321-32 pubmed publisher
  62. Moreira M, Dorneles E, Soares R, Magalhães C, Costa Pereira C, Lage A, et al. Cross-reactivity of commercially available anti-human monoclonal antibodies with canine cytokines: establishment of a reliable panel to detect the functional profile of peripheral blood lymphocytes by intracytoplasmic staining. Acta Vet Scand. 2015;57:51 pubmed publisher
  63. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed publisher
  64. Riou C, Tanko R, Soares A, Masson L, Werner L, Garrett N, et al. Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype. J Immunol. 2015;195:2273-2281 pubmed publisher
  65. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  66. Lenz N, Schindler T, Kagina B, Zhang J, Lukindo T, Mpina M, et al. Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells. Clin Vaccine Immunol. 2015;22:688-96 pubmed publisher
  67. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed publisher
  68. Laing K, Russell R, Dong L, Schmid D, Stern M, Magaret A, et al. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus. J Infect Dis. 2015;212:1022-31 pubmed publisher
  69. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed publisher
  70. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed publisher
  71. Kagina B, Mansoor N, Kpamegan E, Penn Nicholson A, Nemes E, Smit E, et al. Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry. J Immunol Methods. 2015;417:22-33 pubmed publisher
  72. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed publisher
  73. de Thier P, Bacharouche J, Duval J, Skali Lami S, Francius G. Atomic force microscopy analysis of IgG films at hydrophobic surfaces: a promising method to probe IgG orientations and optimize ELISA tests performance. Biochim Biophys Acta. 2015;1854:138-45 pubmed publisher
  74. Bell C, Sun Y, Nowak U, Clark J, Howlett S, Pekalski M, et al. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells. J Autoimmun. 2015;56:66-80 pubmed publisher
  75. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  76. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  77. Huss D, Mehta D, Sharma A, You X, Riester K, Sheridan J, et al. In vivo maintenance of human regulatory T cells during CD25 blockade. J Immunol. 2015;194:84-92 pubmed
  78. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed publisher
  79. Weiskopf D, Angelo M, Bangs D, Sidney J, Paul S, Peters B, et al. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. J Virol. 2015;89:120-8 pubmed publisher
  80. Mylvaganam G, Velu V, Hong J, Sadagopal S, Kwa S, Basu R, et al. Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa. J Immunol. 2014;193:4527-36 pubmed publisher
  81. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher
  82. Kagina B, Tameris M, Geldenhuys H, Hatherill M, Abel B, Hussey G, et al. The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses. Vaccine. 2014;32:5908-17 pubmed publisher
  83. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed publisher
  84. Bending D, Pesenacker A, Ursu S, Wu Q, Lom H, Thirugnanabalan B, et al. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis. J Immunol. 2014;193:2699-708 pubmed publisher
  85. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed publisher
  86. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed publisher
  87. Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson M, Michaelsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014;10:e1004251 pubmed publisher
  88. Payne T, Blackinton J, Frisbee A, Pickeral J, Sawant S, Vandergrift N, et al. Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition. J Virol. 2014;88:9514-28 pubmed publisher
  89. Hebel K, Weinert S, Kuropka B, Knolle J, Kosak B, Jorch G, et al. CD4+ T cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program. J Immunol. 2014;192:5160-70 pubmed publisher
  90. Buggert M, Norstr m M, Salemi M, Hecht F, Karlsson A. Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression. J Immunol. 2014;192:4685-96 pubmed publisher
  91. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  92. Teirlinck A, McCall M, Roestenberg M, Scholzen A, Woestenenk R, de Mast Q, et al. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. 2011;7:e1002389 pubmed publisher
  93. Eddings M, Miles A, Eckman J, Kim J, Rich R, Gale B, et al. Improved continuous-flow print head for micro-array deposition. Anal Biochem. 2008;382:55-9 pubmed publisher
  94. Kooijman R, Coppens A. Insulin-like growth factor-I stimulates IL-10 production in human T cells. J Leukoc Biol. 2004;76:862-7 pubmed